Physiological changes during pregnancy do not appear to effect faecal calprotectin levels – making it more suitable than other biomarkers such as C-reactive protein to assess IBD disease activity. The novel finding is important to help optimise treatment during pregnancy and minimise the risk of adverse outcomes in both mother and baby, when other more ...
Faecal marker of IBD useful in pregnancy
By Mardi Chapman
25 May 2017